Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

11.15 USD +0.23 (+2.11%)
Official Closing Price Updated: 6:16 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,548,623
Open 11.08
Bid (Size) 11.16 (7)
Ask (Size) 11.29 (3)
Prev. Close 10.92
Today's Range 9.690 - 11.19
52wk Range 1.580 - 12.90
Shares Outstanding 98,716,856
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BioCryst Submits Marketing Authorization Application for UK Approval of ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema
From GlobeNewswire News Releases
BioCryst Receives Positive CHMP Opinion for ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema
From GlobeNewswire News Releases

Performance

YTD
+51.08%
+51.08%
1 Month
+5.89%
+5.89%
3 Month
+118.63%
+118.63%
6 Month
+204.64%
+204.64%
1 Year
+217.66%
+217.66%

More News

Read More
BioCryst Reports Fourth Quarter and Full Year 2020 Financial Results and Upcoming Key Milestones
From GlobeNewswire News Releases
BioCryst to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
BioCryst to Report Fourth Quarter and Full Year 2020 Financial Results on February 25
From GlobeNewswire News Releases
BioCryst to Present Data at 2021 American Academy of Allergy, Asthma & Immunology Annual Meeting
From GlobeNewswire News Releases
Is it the right moment for investing in BioCryst Pharmaceuticals shares?
Tags features Market analysis Stocks & shares
From Invezz
Thinking about buying stock in Powerbridge Technologies, BioCryst Pharma, Oramed Pharma, Ampio Pharma, or Plus Therapeutics?
From PR Newswire
BioCryst's Orladeyo Wins EU Positive Opinion For Hereditary Angioedema
Tags General Benzinga News
From Benzinga
Why BioCryst Pharmaceuticals Stock Is Popping Today
Tags BCRX Market News
From Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tags CMRX Markets EDIT
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.